AERI Annual Accounts Receivable
$68.83 M
+$12.81 M+22.86%
31 December 2021
Summary:
As of January 23, 2025, AERI annual accounts receivable is $68.83 million, with the most recent change of +$12.81 million (+22.86%) on December 31, 2021. During the last 3 years, it has risen by +$66.11 million (+2435.10%).AERI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Quarterly Accounts Receivable
$73.88 M
+$5.80 M+8.52%
30 September 2022
Summary:
As of January 23, 2025, AERI quarterly accounts receivable is $73.88 million, with the most recent change of +$5.80 million (+8.52%) on September 30, 2022. Over the past year, it has increased by +$9.31 million (+14.43%).AERI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.9% | +14.4% |
| 3 y3 years | +2435.1% | +122.0% |
| 5 y5 years | +100.0% | - |
AERI Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | at high |
Aerie Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $73.88 M(+8.5%) |
| June 2022 | - | $68.08 M(+7.0%) |
| Mar 2022 | - | $63.62 M(-7.6%) |
| Dec 2021 | $68.83 M(+22.9%) | $68.83 M(+6.6%) |
| Sept 2021 | - | $64.57 M(+9.2%) |
| June 2021 | - | $59.15 M(+28.2%) |
| Mar 2021 | - | $46.15 M(-17.6%) |
| Dec 2020 | $56.02 M | $56.02 M(+19.6%) |
| Sept 2020 | - | $46.85 M(+8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $43.08 M(+0.3%) |
| Mar 2020 | - | $42.94 M(+12.0%) |
| Dec 2019 | $38.35 M(+1312.7%) | $38.35 M(+15.3%) |
| Sept 2019 | - | $33.28 M(+29.7%) |
| June 2019 | - | $25.65 M(+73.8%) |
| Mar 2019 | - | $14.76 M(+443.6%) |
| Dec 2018 | $2.71 M(>+9900.0%) | $2.71 M(+38.4%) |
| Sept 2018 | - | $1.96 M(+74.3%) |
| June 2018 | - | $1.13 M(>+9900.0%) |
| Dec 2017 | $0.00 | $0.00 |
FAQ
- What is Aerie Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals annual accounts receivable year-on-year change?
- What is Aerie Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Aerie Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of AERI is $68.83 M
What is the all time high annual accounts receivable for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high annual accounts receivable is $68.83 M
What is Aerie Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, AERI annual accounts receivable has changed by +$12.81 M (+22.86%)
What is Aerie Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of AERI is $73.88 M
What is the all time high quarterly accounts receivable for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high quarterly accounts receivable is $73.88 M
What is Aerie Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, AERI quarterly accounts receivable has changed by +$9.31 M (+14.43%)